Considering that there are certain advantages and disadvantages among statistical methods in evaluating the performance of biomarkers, we decided to calculate the optimal cut-off level to identify the discriminatory power as well as the clinical applicability of HMGB1 in sepsis rather than compare the levels between survivors and nonsurvivors28,29. Here, HMGB1 is linked to Sepsis.